Product

Isavuconazonium sulfate

Aliases

Cresemba®, isavuconazonium sulfate - intravenous, isavuconazonium sulfate - oral

Name

CRESEMBA

INN Name

isavuconazonium sulfate

FDA Approved

Yes

1 clinical trial

1 organization

1 indication

1 document

Indication

Hematological Malignancy

Clinical trial

A Phase 1, Open-label, Multicenter, Non-comparative Pharmacokinetics and Safety Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients

Status: Completed, Estimated PCD: 2019-07-05

Document

DailyMed Label: CRESEMBA

Organization

Astellas Pharma US, Inc.